Emmanuel Katsanis, MD
Dr. Katsanis has more than 27 years of research experience in tumor and transplant immunology. His work has focused on enhancing anti-leukemia activity in hematopoietic cell transplantation (HCT) and chemo-immuno-therapeutic strategies that promote anti-tumor immune responses while overcoming cancer-induced suppression and elucidating the underlying cellular mechanisms involved.
Throughout his career Dr. Katsanis has had strong collaborations, successfully mentored young investigators and have made significant scientific contributions that have moved from bench to bedside. As a physician-scientist, he provides clinical care for children with cancer and blood disorders and conducts research at the Steele Children’s Research Center.
Dr. Katsanis currently serves on NIH grant study sections, numerous international granting organizations and on journal editorial boards. He has published extensively in the areas of cancer immunology and hematopoietic stem cell transplantation. He has received grants from the Medical Research Council of Canada, the National Institutes of Health, the Department of Defense, the Canadian and American Cancer Societies, and the Leukemia and Lymphoma Society.
Degree(s)
- MD: National University of Athens, Greece, 1980
haploidentical hematopoietic cell transplantation (HHCT), graft versus host disease (GvHD), adoptive T-cell therapy, cancer vaccines, chemo-immunotherapy, immunomodulating agents, experimental HCT models